Ally Bridge Group, a private equity firm that invested in Medtech in December 2015, sold its entire stake of the company to Zimmer Biomet for an undisclosed amount.
Medtech currently offers two FDA-approved surgical robots that allow for minimally invasive brain and spine procedures.
Zimmer Biomet expects the acquisition will boost its presence in the musculoskeletal market.
More articles on supply chain:
Philips partners with Life-Assist to boost AED supplies in west coast
CMS, FDA advocate device ID numbers in medical bills and claims
PhRMA adds 5 new companies to its ranks, including generic rival Teva
